Question 13345 — pharmacy and medications

Summary

Mrs. Laurence Gayte draws the attention of the Minister of Solidarity and Health to the shortage of certain medicines and vaccines in France. In 2017, 530 drugs were out of stock in France, which represents 30% more than in 2016. Among them, anti-cancer drugs, those to fight Parkinson's disease, epilepsy and several vaccines. A shortage which has become more and more accentuated for ten years and which concerns all classes of drugs. The National Medicines Safety Agency, informed of the problem, explains this phenomenon by mentioning the globalization of the manufacture of medicines, difficulties in supplying raw materials or in the production chain, quality defects, but also and above all, restrictive regulations and lower profitability of the molecules of these medicines. He is obligatory for laboratories to report all stock shortages of medicines, but no sanction is provided in the event of a sudden cessation of production. In this regard, certain associations denounce insufficient legislation in this area, endangering the lives of patients, and doctors express their concern. Given the issues raised by this problem, she would like to know what the avenues are proposed by the Government in order to remedy this shortage of vaccines and medicines.

Machine translation from French. The official text remains authoritative.

Timeline

No timeline events have been ingested for this record yet.

Votes

No vote records are attached yet.

Versions

No version snapshots stored. Document URLs remain at the source.

Documents

No documents linked.

Sponsors

No sponsors or actors listed by the source.

Related records

No cross-record relationships stored yet.